Ospedale Luigi Sacco is a hospital in the quartiere of Vialba in Milan, Italy. It was previously known as "sanatorio di Vialba". It is named for Luigi Sacco, an Italian physician who pioneered smallpox research and vaccination in Italy.

During the past decade, ASST FATEBENEFRATELLI SACCO; Oculistica (Sacco) conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ASST FATEBENEFRATELLI SACCO; Oculistica (Sacco)" are "Geographic Atrophy" (4 trials), "Diabetic Macular Edema" (1 trials), "Neovascular Age-related Macular Degeneration" (1 trials) and "Wet Macular Degeneration" (1 trials). Many other conditions were trialed in "ASST FATEBENEFRATELLI SACCO; Oculistica (Sacco)" in a lesser frequency.

Most popular intervention types in "ASST FATEBENEFRATELLI SACCO; Oculistica (Sacco)" are "Drug" (5 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (3 trials), "Sham Procedure" (3 trials), "Aflibercept" (2 trials), "Lampalizumab" (2 trials) and "No intervention" (2 trials). Other intervention names were less common.

The vast majority of trials in "ASST FATEBENEFRATELLI SACCO; Oculistica (Sacco)" are 7 trials for "All" genders.

Currently, there are NaN active trials in "ASST FATEBENEFRATELLI SACCO; Oculistica (Sacco)". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in ASST FATEBENEFRATELLI SACCO; Oculistica (Sacco), undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in ASST FATEBENEFRATELLI SACCO; Oculistica (Sacco), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".